FDA Drug Shortage Database
Sodium acetate shortage
The FDA Drug Shortage Database lists 2 of 15 sodium acetate presentations as limited or unavailable (updated October 1, 2026); the first entry was posted on February 3, 2016. 13 more presentations are on the list as available.
- Generic listed
- In shortage
Check it at the source: the FDA Drug Shortage Database.
Which strengths are short?
| Strength | Limited or unavailable now | Listed now, available | Resolved or discontinued |
|---|---|---|---|
| 20ml injection | 0 | 4 | 0 |
| 50ml injection | 0 | 4 | 0 |
| 100ml injection | 2 | 3 | 0 |
| 164mg/1ml injection | 0 | 2 | 0 |
Which presentations are listed?
Limited or unavailable now (2)
| Presentation | Company | Status and dates | Availability and reason given |
|---|---|---|---|
| Sodium Acetate, Injection, 200 mEq/100 mL (2 mEq/mL) (NDC 0409-3299-06) | Hospira, Inc., a Pfizer Company | Current posted February 3, 2016, updated August 24, 2026 | Limited Availability; Other |
| Sodium Acetate, Injection, 400 mEq/100mL (4 mEq/mL) (NDC 71357-009-10) | Milla Pharmaceuticals | Current posted February 3, 2016, updated October 1, 2026 | Limited Availability; Other |
Listed now, available (13)
| Presentation | Company | Status and dates | Availability and reason given |
|---|---|---|---|
| Sodium Acetate, Injection, 100 mEq/50 mL (2 mEq/mL) (NDC 0409-3299-05) | Hospira, Inc., a Pfizer Company | Current posted February 3, 2016, updated September 22, 2026 | Available |
| Sodium Acetate, Injection, 100 mEq/50 mL (2 mEq/mL) (NDC 0409-3299-26) | Hospira, Inc., a Pfizer Company | Current posted February 3, 2016, updated September 22, 2026 | Available |
| Sodium Acetate, Injection, 100 mEq/50mL (2 mEq/mL) (NDC 0641-6262-01) | Hikma Pharmaceuticals USA, Inc. | Current posted February 3, 2016, updated September 18, 2026 | Available |
| Sodium Acetate, Injection, 100 mEq/50mL (2 mEq/mL) (NDC 71357-007-10) | Milla Pharmaceuticals | Current posted March 23, 2016, updated October 1, 2026 | Available |
| Sodium Acetate, Injection, 164 mg/1 mL (NDC 70069-047-25) | Somerset Therapeutics, LLC | Current posted February 3, 2016, updated September 11, 2026 | Available |
| Sodium Acetate, Injection, 164 mg/1 mL (NDC 70069-048-20) | Somerset Therapeutics, LLC | Current posted February 3, 2016, updated September 11, 2026 | Available |
| Sodium Acetate, Injection, 200 mEq/100 mL (2 mEq/mL) (NDC 0409-3299-25) | Hospira, Inc., a Pfizer Company | Current posted February 3, 2016, updated September 22, 2026 | Available |
| Sodium Acetate, Injection, 200 mEq/100mL (2 mEq/mL) (NDC 71357-008-10) | Milla Pharmaceuticals | Current posted March 23, 2016, updated October 1, 2026 | Available |
| Sodium Acetate, Injection, 4 meq/100 mL (NDC 63323-032-00) | Fresenius Kabi USA, LLC | Current posted March 23, 2016, updated September 15, 2026 | Available |
| Sodium Acetate, Injection, 40 mEq/20 mL (2 mEq/mL) (NDC 0409-7299-25) | Hospira, Inc., a Pfizer Company | Current posted February 3, 2016, updated September 22, 2026 | Available |
| Sodium Acetate, Injection, 40 mEq/20 mL (2 mEq/mL) (NDC 0409-7299-73) | Hospira, Inc., a Pfizer Company | Current posted February 3, 2016, updated September 22, 2026 | Available |
| Sodium Acetate, Injection, 40 mEq/20mL (2 mEq/mL) (NDC 0641-6261-01) | Hikma Pharmaceuticals USA, Inc. | Current posted February 3, 2016, updated September 18, 2026 | Available |
| Sodium Acetate, Injection, 40 mEq/20mL (2 mEq/mL) (NDC 71357-002-10) | Milla Pharmaceuticals | Current posted February 3, 2016, updated October 1, 2026 | Available |
Source: FDA Drug Shortage Database via openFDA, read October 8, 2026
What next?
- Every shortage now
- medicines by presentations in shortage